Soho TVhttp://www.sohotv.org/Articles/ctl/rss/mid/4036RSS document<![CDATA[Exciting Advances and Unanswered Questions with CAR T-Cell Therapy]]>https://www.sohotv.org/Articles/ArtMID/4036/ArticleID/276/Exciting-Advances-and-Unanswered-Questions-with-CAR-T-Cell-TherapyMon, 13 Sep 2021 13:00:00 GMThttps://www.sohotv.org/Articles/ArtMID/4036/ArticleID/276/Exciting-Advances-and-Unanswered-Questions-with-CAR-T-Cell-Therapy<![CDATA[Exciting Aspects in AML Therapies in 2021 and Beyond]]>https://www.sohotv.org/Articles/ArtMID/4036/ArticleID/277/Exciting-Aspects-in-AML-Therapies-in-2021-and-BeyondMon, 13 Sep 2021 13:00:00 GMThttps://www.sohotv.org/Articles/ArtMID/4036/ArticleID/277/Exciting-Aspects-in-AML-Therapies-in-2021-and-Beyond<![CDATA[Emerging Strategies in the Treatment of Hodgkin Lymphoma]]>https://www.sohotv.org/Articles/ArtMID/4036/ArticleID/273/Emerging-Strategies-in-the-Treatment-of-Hodgkin-LymphomaFri, 10 Sep 2021 13:30:00 GMThttps://www.sohotv.org/Articles/ArtMID/4036/ArticleID/273/Emerging-Strategies-in-the-Treatment-of-Hodgkin-Lymphoma<![CDATA[New and Emerging Agents in the Treatment of Diffuse Large B-Cell Lymphoma]]>https://www.sohotv.org/Articles/ArtMID/4036/ArticleID/274/New-and-Emerging-Agents-in-the-Treatment-of-Diffuse-Large-B-Cell-LymphomaFri, 10 Sep 2021 13:00:00 GMThttps://www.sohotv.org/Articles/ArtMID/4036/ArticleID/274/New-and-Emerging-Agents-in-the-Treatment-of-Diffuse-Large-B-Cell-Lymphoma<![CDATA[Hot Topics in Indolent Lymphoma]]>https://www.sohotv.org/Articles/ArtMID/4036/ArticleID/275/Hot-Topics-in-Indolent-LymphomaFri, 10 Sep 2021 12:30:00 GMThttps://www.sohotv.org/Articles/ArtMID/4036/ArticleID/275/Hot-Topics-in-Indolent-Lymphoma<![CDATA[Recent Updates in the Treatment of Myeloproliferative Neoplasms]]>https://www.sohotv.org/Articles/ArtMID/4036/ArticleID/268/Recent-Updates-in-the-Treatment-of-Myeloproliferative-NeoplasmsThu, 09 Sep 2021 18:00:00 GMThttps://www.sohotv.org/Articles/ArtMID/4036/ArticleID/268/Recent-Updates-in-the-Treatment-of-Myeloproliferative-Neoplasms<![CDATA[Hot Topics in Chronic Lymphocytic Leukemia]]>https://www.sohotv.org/Articles/ArtMID/4036/ArticleID/269/Hot-Topics-in-Chronic-Lymphocytic-LeukemiaThu, 09 Sep 2021 17:30:00 GMThttps://www.sohotv.org/Articles/ArtMID/4036/ArticleID/269/Hot-Topics-in-Chronic-Lymphocytic-Leukemia<![CDATA[Recent Developments and Progress in Chronic Myeloid Leukemia]]>https://www.sohotv.org/Articles/ArtMID/4036/ArticleID/272/Recent-Developments-and-Progress-in-Chronic-Myeloid-LeukemiaThu, 09 Sep 2021 17:00:00 GMThttps://www.sohotv.org/Articles/ArtMID/4036/ArticleID/272/Recent-Developments-and-Progress-in-Chronic-Myeloid-Leukemia<![CDATA[CAR-T vs. Bispecific Agents in the Treatment of Refractory Multiple Myeloma]]>https://www.sohotv.org/Articles/ArtMID/4036/ArticleID/270/CAR-T-vs-Bispecific-Agents-in-the-Treatment-of-Refractory-Multiple-MyelomaThu, 09 Sep 2021 16:30:00 GMThttps://www.sohotv.org/Articles/ArtMID/4036/ArticleID/270/CAR-T-vs-Bispecific-Agents-in-the-Treatment-of-Refractory-Multiple-Myeloma<![CDATA[MRD Directed Therapeutic Decision Making in Multiple Myeloma]]>https://www.sohotv.org/Articles/ArtMID/4036/ArticleID/271/MRD-Directed-Therapeutic-Decision-Making-in-Multiple-MyelomaThu, 09 Sep 2021 16:00:00 GMThttps://www.sohotv.org/Articles/ArtMID/4036/ArticleID/271/MRD-Directed-Therapeutic-Decision-Making-in-Multiple-Myeloma